Abstract:
Pityriasis versicolor is a chronic superficial fungal disease that is characterized
by the appearance of round to oval lesions, most commonly found on the trunk
and upper aspects of the arms. The objectives of this study were to isolate and
characterize the cutaneous Malassezia in patients with pityriasis versicolor and
healthy individuals, as well as to study the antifungal activity of common
antifungal agents against the isolated Malassezia species.
A total of 370 scale samples were collected (140 by moist cotton swabs and
230 by OpsiteTM transparent dressing to lesional and non-lesional sites) from
patients suspected of having Pityriasis versicolor and healthy individuals in
Khartoum and Gedarif States. Swabs samples (n=140) were cultured on
Sabouraud’s Dextrose agar with Olive oil and the isolated colonies were
identified on the base of colonial morphology, microscopic examination and
biochemical tests. DNA was extracted from the yielded colonies and directly
from the Opsite tapes, then amplified by PCR, sequenced and analyzed by real-
time PCR using a TaqMan probe. Antifungal susceptibility of the isolates to
nine antifungal including azoles and other antifungal agents (amphotericin B,
micafungin, anidulafungin, fluconazole, itraconazole, 5-flucytosine,
voriconazole, posaconazole and caspofungin) was tested via the Sensititre
Yeast One system. Obtained data were analysed using SPSS programme.
Twenty eight isolates (20%) were identified according to colonial morphology,
microscopic examination and biochemical tests as Malassezia species while
other 112 (80%) showed negative growth. After PCR amplification and DNA
sequencing 18 (64.3%) out of 28 isolates were found to be Malassezia furfur,
and 10 (35.7%) ruled out of Malassezia which were found as Pichia
mandshurica, Cryptococcus albidus and Clavispora lusitaniae. DNAs of
Malassezia globosa and Malassezia restricta were detected in 71.7% and
21.8%, respectively in P.V patients. The distribution of M. globosa and M.
restricta in P.V patients were higher (60.9%) in 20-30 age group and lower
(1.1%) in 61-70 age group. On the other hand, the distribution of M. globosa
and M. restricta in healthy subjects, males and females were higher (38.6% and
56.2%) in 20-30 age, and lower (8.6% and 6.8%) in 61-70 age. The overall
level of colonization by Malassezia at the lesional sites was higher than that at
the non-lesional sites for all body sites, including the face, neck, cheeks, and
trunk (2.7- to 6.0-fold increase) (P< 0.05).
Posaconazole (POS), Voriconazole (VOR) and Itraconazole (ITZ) were highly
active against isolates of M. furfur since all isolates were inhibited by 0.06-0.12
μg/mL, 0.015-0.03 μg/mL and 0.25 μg/mL respectively. Amphotericin B and
caspofungin have high MICs and low in vitro activities against M. furfur
isolates, since most isolates were inhibited by 8μg/ml of amphotericin B,
0.5μg /ml of caspofungin and 1 μg/mL of fluconazole.
This study indicates that M. furfur strains were susceptible to ITZ, VOR and
POS. The Sensititre Yeast One seems to be a suitable commercial tool for the
antifungal susceptibility of Malassezia. Moreover, the study confirmed that
both DNAs of M. globosa and M. restricta can be detected in healthy subjects,
although M. restricta was predominant in both sexes with slight difference in
colonization level between males and females. M. furfur was susccefully
isolated from scale samples of both patients and healthy subjects while other
species, M. globosa and M. restricta were not isolated on cultures and found
only after molecular characterization by real- time PCR directly from the
specimen. M. globosa was predominant in Sudanese patients with pityriasis
versicolor. Further studies are required in different part to establish a solid base
for research on the basic molecular biology of Malassezia fungus in Sudan.